PubRank

J Casper

Author PubWeight™ 72.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 1989 2.21
2 What is the value added by human intervention in protein structure prediction? Proteins 2001 1.97
3 Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 1981 1.92
4 Participation of veterinarians in disaster management. J Am Vet Med Assoc 1997 1.45
5 Headache after hematopoietic stem cell transplantation: being aware of chronic bilateral subdural hematoma. Leuk Lymphoma 2006 1.40
6 Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000 1.26
7 Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 1999 1.17
8 Failure of daily lumbar punctures to prevent the development of hydrocephalus following intraventricular hemorrhage. J Pediatr 1980 1.09
9 Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells. Int J Cancer 1994 1.09
10 Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 1999 1.06
11 Nonrandom chromosome alterations in rhabdomyosarcoma. Cancer Genet Cytogenet 1985 1.06
12 Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 1996 1.05
13 Diagnosis and treatment of persistent dysphonia after laryngeal surgery: a retrospective analysis of 62 patients. Laryngoscope 1994 1.04
14 Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread. Urol Int 2008 1.03
15 Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol 2001 1.02
16 Stroboscopic signs associated with benign lesions of the vocal folds. J Voice 1995 1.00
17 Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant 2005 0.96
18 Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity. Cancer 1981 0.96
19 Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 1991 0.95
20 Endoscopic microsuture repair of vocal fold defects. J Voice 1995 0.94
21 Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs 1997 0.93
22 Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant 2005 0.92
23 High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991 0.91
24 Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clin Cancer Res 2000 0.90
25 Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996 0.90
26 The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol 1998 0.90
27 Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997 0.89
28 Environmental disasters and veterinarians' response. J Am Vet Med Assoc 1993 0.89
29 Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. Bone Marrow Transplant 2002 0.87
30 Dysphonia in the aging: physiology versus disease. Laryngoscope 1992 0.87
31 Aerodynamic and stroboscopic findings before and after microlaryngeal phonosurgery. J Voice 1994 0.86
32 T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transplant 1998 0.86
33 Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 1980 0.86
34 The introduction in 1928-29 of thorium dioxide in diagnostic radiology. Ann N Y Acad Sci 1967 0.86
35 Cell lines of human germinal cancer. Int J Androl 1987 0.84
36 Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplant 2006 0.83
37 Chemotherapy-associated supravenous hyperpigmentation. Dermatology 1996 0.83
38 An overview of disaster preparedness for veterinarians. J Am Vet Med Assoc 1997 0.83
39 Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. Bone Marrow Transplant 1988 0.82
40 Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Transplant 1992 0.82
41 Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer. Anticancer Drugs 2000 0.82
42 A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma. Ann Oncol 1992 0.82
43 Epidemiology of cancers of uterine cervix and corpus, breast and ovary in Israel and New York City. J Natl Cancer Inst 1966 0.81
44 Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood 1989 0.81
45 Peritoneal hemangioendotheliomatosis after salpingography with thorotrast. Ann N Y Acad Sci 1967 0.80
46 Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): a multicenter POG pilot study. Prog Clin Biol Res 1988 0.80
47 Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG). Int J Cancer 1999 0.80
48 Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. Leuk Res 1982 0.80
49 Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant 2007 0.80
50 Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma. Scand J Immunol 1997 0.80
51 Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support. Eur J Cancer 2003 0.80
52 Loss of the GVL effect by loss of the Y-chromosome as putative mechanism of immune escape in ALL. Bone Marrow Transplant 2005 0.79
53 Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome. Bone Marrow Transplant 2010 0.79
54 Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 2001 0.79
55 Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia. Mayo Clin Proc 1994 0.79
56 T-cell-depleted stem cell boost for the treatment of autoimmune haemolytic anaemia after T-cell-depleted allogeneic bone marrow transplantation complicated by adenovirus infection. Bone Marrow Transplant 2006 0.78
57 The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 1992 0.78
58 Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine. Cancer Treat Rep 1986 0.78
59 Valence tautomerism of singly protonated 9-aminoacridine and its implications for intercalative interactions with nucleic acids. J Pharm Sci 1974 0.78
60 Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy. Am J Pediatr Hematol Oncol 1990 0.78
61 Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994 0.78
62 Congenital macrodactyly. A case report with a three-year follow-up. J Bone Joint Surg Br 1966 0.77
63 Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro. Cancer 1989 0.77
64 Phase II study of carboplatin in untreated inoperable advanced stomach cancer. Eur J Cancer 1990 0.77
65 High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation. Bone Marrow Transplant 2004 0.77
66 Cell surface lectins of transplantable human teratocarcinoma cells: purification of a new mannan-specific endogenous lectin. Tumour Biol 1985 0.77
67 Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 1990 0.77
68 Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. Neoplasma 2005 0.77
69 Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents. Eur J Cancer 1990 0.77
70 Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. J Cancer Res Clin Oncol 2011 0.77
71 Functional staging for vocal cord paralysis. Otolaryngol Head Neck Surg 1991 0.77
72 Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. Bone Marrow Transplant 2010 0.77
73 The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna. Br J Cancer 1994 0.77
74 Physiological characteristics of the supported singing voice. A preliminary study. J Voice 1995 0.76
75 Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHD. Eur J Haematol 2004 0.76
76 Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts. Invest New Drugs 1997 0.76
77 Toward the total rehabilitation of the alaryngeal patient. Laryngoscope 1979 0.76
78 Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer. Anticancer Drugs 1996 0.76
79 Quantification of additional short arms of chromosome 12 in germ cell tumours using the polymerase chain reaction. Eur J Cancer 1997 0.76
80 [Changes in hemostasis of dogs with acute lymphoblastic leukemia]. Berl Munch Tierarztl Wochenschr 1998 0.76
81 Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts. Int J Androl 1987 0.75
82 Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Ann Hematol 2002 0.75
83 Necropsy procedures used at the Maryland Department of Agriculture Animal Health Laboratory. Vet Med Small Anim Clin 1981 0.75
84 Integration of veterinarians into the official response to disasters. J Am Vet Med Assoc 1997 0.75
85 Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines. Invest New Drugs 1990 0.75
86 Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. Hum Gene Ther 1998 0.75
87 Management of other non-cisplatin-induced emesis. Oncology 1996 0.75
88 Exchange transfusion for Reye's syndrome. J Surg Res 1975 0.75
89 Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. Med Pediatr Oncol 1980 0.75
90 Rare coincidence of hypertriploid chromosome number and aberrant coexpression of the lymphoid-associated antigen CD5 in acute myeloid Leukaemia FAB M0. Leukemia 2003 0.75
91 Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines. J Cancer Res Clin Oncol 1998 0.75
92 Ultrastructural analysis of colonies growing in a human tumor cloning system. Cancer 1982 0.75
93 Characterization of rearranged Y chromosomes in human testicular tumor cell lines. Cancer Genet Cytogenet 1989 0.75
94 [Erdheim-Chester disease of the orbit with compressive optic neuropathy]. Ophthalmologe 2010 0.75
95 Fiber-optic video study of the post-laryngectomized voice. Laryngoscope 1975 0.75
96 Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2007 0.75
97 Visual deterioration after Gram-negative sepsis in neutropenia. Ann Hematol 2007 0.75
98 Disorders of speech and voice. Pediatr Ann 1985 0.75
99 Cellular oncogenes in human teratocarcinoma cell lines. Int J Androl 1990 0.75
100 Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping. Transplant Proc 1991 0.75
101 Solid carcinoma with amyloid of the thyroid gland--a clinicopathologic entity. Review of ten cases. Arch Surg 1968 0.75
102 Interaction of human embryonal carcinoma cells and differentiated derivatives in vitro with simian virus 40, human adenovirus type 7, or PARA. Exp Cell Res 1990 0.75
103 Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation. Ann Oncol 2013 0.75
104 Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997 0.75
105 Comparison of endogenous lectins in human embryonic carcinoma and yolk sac carcinoma. Tumour Biol 1986 0.75
106 Unroofing of Pulmonary Tuberculous Cavities. Trans Am Climatol Clin Assoc 1932 0.75
107 Motor disorders of voice and speech in Reye's syndrome survivors. Am J Dis Child 1984 0.75
108 Extraosseous uptake of 99mtechnetium methylene diphosphonate: neuroblastoma or radiation therapy. Pediatr Radiol 1980 0.75
109 No growth-stimulation of heterotransplanted human testicular cancer cell-lines by recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf). Int J Oncol 1993 0.75
110 High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize. Ann Hematol 2001 0.75
111 The Martin Dewey Memorial Award for 1972. Am J Orthod 1973 0.75
112 [10 years transplantation of bone marrow and hematopoietic stem cells in adults at the Hannover Medical School]. Med Klin (Munich) 1996 0.75
113 Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood 1995 0.75
114 [Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2002 0.75